Orient Europharma Co (4120.TWO) Stock Price
Orient Europharma Co Price
Over the last 19 years Orient Europharma Co grew revenue by 3.2% annually, reaching 4.60 B TWD. Earnings per share have declined at 0.4% per year over the last 17 years. For Orient Europharma Co, the net margin of -12.3% is down versus 2.5% a few years ago. At today's price the dividend yield works out to roughly 2.30%. The dividend has grown at 5.6% per year over the past 3 years.
Orient Europharma Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Orient Europharma Co business model & stock analysis
Frequently asked questions about Orient Europharma Co
Converted at the current exchange rate, the Orient Europharma Co share trades at 1.19 EUR (43.40 TWD).
The revenue cannot currently be calculated for Orient Europharma Co.
The profit cannot currently be calculated for Orient Europharma Co.
The P/E ratio cannot be calculated for Orient Europharma Co at the moment.
The P/S cannot be calculated for Orient Europharma Co currently.
The Eulerpool Quality Score for Orient Europharma Co is 1/10.
The ISIN of Orient Europharma Co is TW0004120001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Orient Europharma Co is 4120.TWO. The ticker symbol is used to trade Orient Europharma Co shares on the stock exchange.
Orient Europharma Co stock
Orient Europharma Co Peer Group
Orient Europharma Co FIGI
All fundamentals and in-depth analysis of Orient Europharma Co
Our stock analysis for Orient Europharma Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orient Europharma Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.